Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
Abattis Bioceuticals Market Cap
Abattis Bioceuticals has a market cap or net worth of $476.00 as of July 16, 2025.
Market Cap
476.00
Enterprise Value
n/a
Revenue
269.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 476.00, a decrease of -99.97%. That is a compound annual growth rate of -46.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 857.64M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 553.58M |
| Glass House Brands | 545.56M |
| CytoDyn | 394.14M |
| American Oncology Network | 343.79M |